Romania's pharmaceutical sector demonstrates resilience despite fiscal consolidation and slowing economic growth, according to Allianz Trade's latest analysis.
World Bank indicators show a favorable business environment in Romania, but corruption remains a challenge.
According to the report, the global economy reached a trough in the first half of 2024, with the outlook for the end of this year and 2025 indicating a modest rebound
Romania's GDP fell by 0.2% in Q1 2026 compared to the previous quarter, according to data released by the National Institute of Statistics (INS).
Romania's annual inflation rate reached 10.7% in April 2026 compared to April 2025, according to data released by the National Institute of Statistics (INS).
Agroland Business System has received approval from Romania's Commission for the Examination of Foreign Direct Investments (CEFDI) for a €20 million greenfield investment in egg production. The new facility will be located in Mihăilești, Giurgiu County.
The European Investment Bank (EIB) will advise Antibiotice, Romania's largest pharmaceutical company with majority Romanian capital, on strengthening its corporate governance to support future growth. Under a new advisory services agreement, the EIB will work with Antibiotice to align its risk-management framework and business operations with international best practice in the pharmaceutical sector.
Penny Romania ended 2025 with revenue of RON 10.6 billion lei (€2.1 billion), marking a 12.01% increase compared to the previous year. The discount retailer opened 40 new stores, reaching 456 units nationwide, and completed its fifth logistics centre in Mihăilești, Giurgiu County.